GL1X · GenesisL1 explorer

Research workbench

SARS cov-2 plpro in complex with ISG15 C-terminal domain propargylamide

Analyse SARS cov-2 plpro in complex with ISG15 C-terminal domain propargylamide in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6XA9
Type
protein
Length
1,168 residues
Chains
6
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Non-structural protein 3; ISG15 ctd-propargylamide
EC
3.4.19.121, 3.4.22.-
UniProt
P0DTD1, P05161
Ligands
AYE, ZN
Pockets
14 · best druggability 0.77

Structure

x-ray diffraction · 4 distinct chains · 25% helix, 37% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, CNon-structural protein 3 (EC 3.4.19.121, 3.4.22.-)protein31326% helix, 37% strandP0DTD1
BISG15 ctd-propargylamideprotein7920% helix, 34% strandP05161
D, FISG15 ctd-propargylamideprotein7824% helix, 35% strandP05161
ENon-structural protein 3 (EC 3.4.19.121, 3.4.22.-)protein30726% helix, 37% strandP0DTD1

Ligands and binding sites

  • AYE · prop-2-en-1-amine · ligand · 3 copies · chains A, B, C, D, E, F
  • ZN · Zinc ion · metal · 3 copies · chains A, C, E
  • GOL · Glycerol · additive · 8 copies · chains A, C, E

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

14 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111460.770.79108AYE
25110.700.8059empty
34820.690.8047empty
43790.630.7843empty
51930.470.7533empty

Interfaces

9 interfaces between chains.

  • A–B · 889 Ų buried · 12 hydrogen bonds · protein-protein
  • E–F · 884 Ų buried · 17 hydrogen bonds · protein-protein
  • C–D · 873 Ų buried · 15 hydrogen bonds · protein-protein
  • A–C · 623 Ų buried · 1 hydrogen bond · protein-protein
  • A–E · 377 Ų buried · 5 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 covalent (covalent ligand).

Compared structures

  • 6XA9 · SARS CoV-2 PLpro in complex with ISG15 C-terminal domain propargylamide · the same entry in another collection · chain F against F, TM-score 1.00
  • P05161 · AlphaFold monomer V2.0 prediction for ubiquitin-like protein ISG15 (P05161) · a predicted model of the same protein · chain B against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.